163 related articles for article (PubMed ID: 37591290)
1. Phase 3 trial results bring hope for patients with IgA nephropathy.
Haraldsson B
Lancet; 2023 Sep; 402(10405):827-829. PubMed ID: 37591290
[No Abstract] [Full Text] [Related]
2. Pathophysiology and treatment of IgA nephropathy in children.
Yoshikawa N; Tanaka R; Iijima K
Pediatr Nephrol; 2001 May; 16(5):446-57. PubMed ID: 11405121
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
[TBL] [Abstract][Full Text] [Related]
4. Treatment for IgA nephropathy.
Tomino Y
Contrib Nephrol; 2007; 157():8-12. PubMed ID: 17495431
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiology and treatment of IgA nephropathy].
Bollin R; Haller H
Internist (Berl); 2018 Jul; 59(7):736-740. PubMed ID: 29946875
[TBL] [Abstract][Full Text] [Related]
6. [IgA nephropathy].
Haaskjold YL; Knoop T
Tidsskr Nor Laegeforen; 2022 Nov; 142(16):. PubMed ID: 36345626
[TBL] [Abstract][Full Text] [Related]
7. Emerging Modes of Treatment of IgA Nephropathy.
Maixnerova D; Tesar V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260613
[TBL] [Abstract][Full Text] [Related]
8. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
[TBL] [Abstract][Full Text] [Related]
9. New strategies and perspectives on managing IgA nephropathy.
Selvaskandan H; Cheung CK; Muto M; Barratt J
Clin Exp Nephrol; 2019 May; 23(5):577-588. PubMed ID: 30756248
[TBL] [Abstract][Full Text] [Related]
10. Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse.
Tomino Y
Clin Exp Nephrol; 2011 Feb; 15(1):1-7. PubMed ID: 21057848
[TBL] [Abstract][Full Text] [Related]
11. Elderly patients with glomerular diseases and IgA nephropathy.
Lin J; Cheng Z; Qian Q
Nephrology (Carlton); 2017 Dec; 22 Suppl 4():20-26. PubMed ID: 29155502
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic IgA nephropathy: pathogenesis, histopathology, and therapeutic options.
Tumlin JA; Madaio MP; Hennigar R
Clin J Am Soc Nephrol; 2007 Sep; 2(5):1054-61. PubMed ID: 17702711
[TBL] [Abstract][Full Text] [Related]
13. [Effects of tonsillectomy on juvenile nephritis, involving IgA nephropathy, purpura nephritis and chronic and persistent glomerulonephritis].
Maeda H; Amatsu H; Tsuda M
Nihon Jibiinkoka Gakkai Kaiho; 1986 Sep; 89(9):1167-71. PubMed ID: 3794853
[No Abstract] [Full Text] [Related]
14. Therapies in patients with IgA nephropathy.
Tsuboi N; Kawamura T
Intern Med; 2014; 53(7):649-50. PubMed ID: 24694470
[No Abstract] [Full Text] [Related]
15. Addition of immunosuppression to comprehensive supportive care did not benefit patients with IgA nephropathy.
Lalayiannis AD; Lalayiannis AD
Arch Dis Child Educ Pract Ed; 2017 Feb; 102(1):56. PubMed ID: 27609604
[No Abstract] [Full Text] [Related]
16. Treatment of IgA nephropathy: Recent advances and prospects.
Coppo R
Nephrol Ther; 2018 Apr; 14 Suppl 1():S13-S21. PubMed ID: 29606258
[TBL] [Abstract][Full Text] [Related]
17. Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis.
Streather CP; Scoble JE
Nephron; 1994; 66(1):113-4. PubMed ID: 8107943
[No Abstract] [Full Text] [Related]
18. [IgA nephropathy].
Sakai H
Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):95-8. PubMed ID: 9277693
[No Abstract] [Full Text] [Related]
19. Treatment of IgA nephropathy.
Peh CA; Clarkson AR
Nephrol Dial Transplant; 1995; 10(7):1119-21. PubMed ID: 7478107
[No Abstract] [Full Text] [Related]
20. [Various types of glomerulonephritis. Mesangium proliferative glomerulonephritis--IgA nephropathy].
Shirato I
Nihon Rinsho; 1988 Jun; 46(6):1258-61. PubMed ID: 3047458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
